about
Is increasing complexity of algorithms the price for higher accuracy? virtual comparison of three algorithms for tertiary level management of chronic cough in people living with HIV in a low-income countryContinuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancerCD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.Molecular classification of T-cell lymphomas.New biomarkers in T-cell lymphomas.Does introduction of thresholds in decision aids benefit the patient?: Comparison between findings-based and threshold-based diagnostic decision aids.Weighing harm in therapeutic decisions of smear-negative pulmonary tuberculosis.Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: implications for tumor recurrence.Local applications of GM-CSF induce the recruitment of immune cells in cervical low-grade squamous intraepithelial lesions.Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended.Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.Primary γδ T cell lymphoma of the lung: report of a case with features suggesting derivation from intraepithelial γδ T lymphocytes.Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue.Why are clinicians reluctant to treat smear-negative tuberculosis? An inquiry about treatment thresholds in Rwanda.Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.Microfluidics-assisted fluorescence in situ hybridization for advantageous human epidermal growth factor receptor 2 assessment in breast cancer.Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.Primary mucosa-associated lymphoid tissue lymphoma of the gallbladder: report of a case harboring API2/MALT1 gene fusion.Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly.Malignant transformation of a β-catenin inflammatory adenoma due to an S45 β-catenin-activating mutation present 12 years before.Gray platelet syndrome: Novel mutations of the NBEAL2 gene.Cutaneous presentation of hepatosplenic T-cell lymphoma-a potential mimicker of primary cutaneous gamma-delta T-cell lymphoma.B-cell lymphomas with discordance between pathological features and clinical behavior.[Molecular oncogenesis of lymphomas: role of the SETD2 gene in intestinal T-cell lymphomas].Papillary thyroid carcinoma with nodular fasciitis-like stroma and β-catenin mutations should be renamed papillary thyroid carcinoma with desmoid-type fibromatosisAn Unusual Uterine Tumor With Signet Ring Cell Featuresc-Maf expression in angioimmunoblastic T-cell lymphoma reflects follicular helper T-cell derivation rather than oncogenesisCHIC cells: a novel ALK+ cell line derived from a relapsed anaplastic large cell lymphomaHuman papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretionPrimary central nervous system lymphoma in a patient treated with Natalizumab[Fish and chips]Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression
P50
Q34133125-055814F2-A7EE-4650-9DB0-5EA65E8D3689Q36559818-847FF1F6-0AB6-4C4D-911B-CF514FF7F818Q37060660-6156D42E-6061-4D9B-B8A1-A7E78015729FQ37257158-9071C83C-7EA7-4700-8D0C-E06E307BC1EFQ37398316-09498A60-6EC5-4AEC-8DB2-5F76EC3FBB3AQ37992723-9A174147-A492-4413-AC85-A8A7D3134A3DQ38910148-9B4ABBF0-D05B-43E1-B7C5-9470AB688144Q39267642-5277850F-F5E4-4661-B8AF-00235BD8D6D9Q39412402-0D6E85D2-83AA-4199-906C-D0D86682E35DQ39718884-D98F08F9-E972-4F05-BB56-981234E53EF3Q40856391-316FCB2B-45F6-4C1D-85FC-049FBC71E210Q41134958-7FA885EA-40B1-4E33-8336-B07691CFD29BQ42206063-626DC405-F1B4-4C8D-AC4B-5CCDEE417703Q45162906-527B841E-CD47-4344-95ED-5151959D17BEQ46705914-85AB2910-1491-45DF-B89F-551098218456Q48177867-7571914D-83DF-4605-821D-2CA6C8510041Q48194558-B9E8EE68-2B85-4B37-8396-4462D9463137Q48272046-B0EA7A20-541F-4C20-97AE-B39C0298840AQ50154544-2DB39559-8B5D-4A1A-AFF5-7F7173DB14FCQ50477659-88337C33-2641-46B4-9996-652D623AE679Q51007008-BB94C0A1-46BB-443D-ADF5-F6C83DD36BA0Q51313575-5BD74408-74AB-440A-B5A1-D2355507A88AQ51549659-BB15CD13-F354-49D7-96BF-DCC29778D64CQ52863282-AFD754E5-A92C-44F7-B432-39B27C4E7013Q53789627-D7CEBE6C-DC13-4126-AADB-C0946B72A83CQ57580259-C1DE97D2-C746-42D0-BA37-541CDF9DCE19Q57580296-C0B6280E-51A8-4DF5-B1D5-48EE9AD6B699Q57580305-955FADA1-DE1A-4103-B56D-D27BEE147508Q57580311-B74D2C61-3998-41BF-BFF1-EA4F4373606AQ57580316-6B4E1D96-B129-4C55-8431-487E57B5F2B3Q57580323-D05A97CF-56AE-4947-A3DC-C5E77A952B84Q57580329-5495133C-548F-4F23-801B-A4B1FB529813Q57580345-8F3C93AD-8341-493B-B27D-E8312B88101F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bettina Bisig
@ast
Bettina Bisig
@en
Bettina Bisig
@es
Bettina Bisig
@nl
Bettina Bisig
@sl
type
label
Bettina Bisig
@ast
Bettina Bisig
@en
Bettina Bisig
@es
Bettina Bisig
@nl
Bettina Bisig
@sl
prefLabel
Bettina Bisig
@ast
Bettina Bisig
@en
Bettina Bisig
@es
Bettina Bisig
@nl
Bettina Bisig
@sl
P106
P21
P31
P496
0000-0002-6840-375X